Search results

Articles (5)

Journals (0)

1-5 of 5 results for IQWiG

Sort by:

Relevance

Select all

Sort by:

Relevance

Restricted accessResearch articleFirst published November, 2013

A theoretical and empirical investigation into the willingness-to-pay function for new innovative drugs by Germany’s health technology assessment agency (IQWiG)

Afschin Gandjour

Health Services Management Research

Restricted accessResearch articleFirst published February, 2017

Cost Recommendation under Uncertainty in IQWiG’s Efficiency Frontier Framework

Isaac Corro Ramos, Stefan K. Lhachimi, Andreas Gerber-Grote [...]

Medical Decision Making

Free accessResearch articleFirst published January, 2016

IQWiG Reanalyzes and Raises Questions About an Article by Ly et al Which Concluded Low Glucose Suspend Is Very Beneficial

Lutz Heinemann, Norbert Hermanns

Journal of Diabetes Science and Technology

Open accessResearch articleFirst published May, 2024

A Comparison of Additional Benefit Assessment Methods for Time-to-Event Endpoints Using Hazard Ratio Point Estimates or Confidence Interval Limits by Means of a Simulation Study

Christopher A. Büsch, Marietta Kirchner, Rouven Behnisch [...]

Medical Decision Making

Restricted accessResearch articleFirst published November, 2014

Early Benefit Assessment of Pharmaceuticals in Germany

Katharina E. Fischer, Tom Stargardt

Medical Decision Making

Search results

Articles (5)

Journals (0)

1-5 of 5 results for IQWiG

Sort by:

Relevance

Select all

Sort by:

Relevance

Restricted accessResearch articleFirst published November, 2013

A theoretical and empirical investigation into the willingness-to-pay function for new innovative drugs by Germany’s health technology assessment agency (IQWiG)

Afschin Gandjour

Health Services Management Research

Restricted accessResearch articleFirst published February, 2017

Cost Recommendation under Uncertainty in IQWiG’s Efficiency Frontier Framework

Isaac Corro Ramos, Stefan K. Lhachimi, Andreas Gerber-Grote [...]

Medical Decision Making

Free accessResearch articleFirst published January, 2016

IQWiG Reanalyzes and Raises Questions About an Article by Ly et al Which Concluded Low Glucose Suspend Is Very Beneficial

Lutz Heinemann, Norbert Hermanns

Journal of Diabetes Science and Technology

Open accessResearch articleFirst published May, 2024

A Comparison of Additional Benefit Assessment Methods for Time-to-Event Endpoints Using Hazard Ratio Point Estimates or Confidence Interval Limits by Means of a Simulation Study

Christopher A. Büsch, Marietta Kirchner, Rouven Behnisch [...]

Medical Decision Making

Restricted accessResearch articleFirst published November, 2014

Early Benefit Assessment of Pharmaceuticals in Germany

Katharina E. Fischer, Tom Stargardt

Medical Decision Making